Synthetic mRNA that's been optimized, modified, and formulated to spur the production of bispecific antibodies in the liver can eradicate large tumors in mice. The strategy circumvents some of the manufacturing challenges associated with conventional antibody production and creates a therapeutic that's easier and more convenient to administer.
http://ift.tt/2uROjlS
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου